BIT Capital GmbH Makes New $13.64 Million Investment in Omada Health, Inc. $OMDA

BIT Capital GmbH purchased a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 616,873 shares of the company’s stock, valued at approximately $13,639,000. BIT Capital GmbH owned approximately 1.07% of Omada Health at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Strs Ohio bought a new stake in Omada Health in the 3rd quarter valued at about $38,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health during the 2nd quarter valued at $32,000. Rakuten Investment Management Inc. purchased a new stake in Omada Health during the 3rd quarter worth about $49,000. JPMorgan Chase & Co. bought a new position in Omada Health in the 3rd quarter worth about $82,000. Finally, Rhumbline Advisers bought a new position in Omada Health in the 3rd quarter valued at $176,000.

Insider Buying and Selling at Omada Health

In other Omada Health news, CEO Sean P. Duffy sold 230,479 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $15.60, for a total value of $3,595,472.40. Following the completion of the sale, the chief executive officer directly owned 126,644 shares in the company, valued at $1,975,646.40. This trade represents a 64.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. This represents a 7.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 276,893 shares of company stock valued at $4,336,787.

Omada Health Stock Performance

NASDAQ OMDA opened at $11.89 on Friday. The company’s 50-day simple moving average is $14.58 and its two-hundred day simple moving average is $19.20. The company has a market capitalization of $688.55 million and a price-to-earnings ratio of -47.56. Omada Health, Inc. has a one year low of $10.28 and a one year high of $28.40.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on OMDA. Barclays cut their price objective on Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a report on Monday, January 5th. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a research report on Thursday, January 22nd. Morgan Stanley set a $32.00 price objective on Omada Health in a research note on Thursday, December 18th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $26.00 price objective on shares of Omada Health in a research note on Friday, January 16th. Finally, Evercore upped their target price on Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $25.10.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.